NCT06380231 is a NA clinical trial of kangaroo mother care (KMC) in Kangaroo-mother Care, sponsored by Istanbul Rumeli University.

Who is sponsoring NCT06380231?

NCT06380231 is sponsored by Istanbul Rumeli University.

What drugs are being tested in NCT06380231?

Interventions in NCT06380231: kangaroo mother care (KMC).

What condition does NCT06380231 study?

NCT06380231 studies Kangaroo-mother Care.

Is NCT06380231 still recruiting?

NCT06380231 is currently completed. Last updated 23 April 2024.

Last reviewed 2024-04-23 · How we verify

NCT06380231

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Skin-to-skin Contact Between Premature Infant and Mother

Completed NA Last updated 23 April 2024

What this trial tests

NA trial testing kangaroo mother care (KMC) in Kangaroo-mother Care in 76 participants. Completed in 1 December 2020.

Timeline

1 November 2019

Primary endpoint
1 December 2019

1 December 2020

Quick facts

Lead sponsor	Istanbul Rumeli University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	76
Start date	1 November 2019
Primary completion	1 December 2019
Estimated completion	1 December 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

kangaroo mother care (KMC)

Conditions studied

Kangaroo-mother Care — all drugs for Kangaroo-mother Care →

Sponsor

Istanbul Rumeli University

Who can join

Adults 24 Weeks to 37 Weeks, any sex, with Kangaroo-mother Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: To determine the effect of kangaroo mother care (KMC) on perfusion index, heart rate, and oxygen saturation in premature infants who were discharged early and admitted to the neonatal intensive care in the following days.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul Rumeli University trials

Trials by the same sponsor.

NCT07494734 — MANUAL THERAPY ON PAIN, DISABILITY AND QUALITY OF LIFE · NA · enrolling by invitation
NCT07486232 — INVESTIGATION OF THE EFFECTS OF POSTURAL EXERCISES AND TAPING · NA · enrolling by invitation
NCT07489014 — The Effects of Mulligan Joint Mobilization and Instrument-Assisted Soft Tissue Mobilization in Individuals With Neck Pai · NA · enrolling by invitation
NCT07477847 — The Effects of a Customized Exercise Program on Pain, Kyphosis Angle, and Quality of Life · NA · enrolling by invitation
NCT07474597 — Investigation of the Effectiveness of Myofascial Release Techniques Applied to the Popliteus Muscle in Individuals With · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06380231 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Rumeli University
Last refreshed: 23 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06380231.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing